584 related articles for article (PubMed ID: 35021975)
1. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
Nehra B; Mathew B; Chawla PA
Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
Kumar D; Jain SK
Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
[TBL] [Abstract][Full Text] [Related]
3. Current Developments in the Pyran-Based Analogues as Anticancer Agents.
Grover P; Bhardwaj M; Mehta L; Kapoor G; Chawla PA
Anticancer Agents Med Chem; 2022; 22(19):3239-3268. PubMed ID: 34802409
[TBL] [Abstract][Full Text] [Related]
4. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
5. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies.
Sahil ; Kaur K; Jaitak V
Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box.
Martins P; Jesus J; Santos S; Raposo LR; Roma-Rodrigues C; Baptista PV; Fernandes AR
Molecules; 2015 Sep; 20(9):16852-91. PubMed ID: 26389876
[TBL] [Abstract][Full Text] [Related]
7. Recent Developments in the Antimicrobial Potential of Some Nitrogenous Heterocycles and their SAR Studies: A Review.
Nehra B; Kumar M; Singh S; Chawla V; A Chawla P; Grover P
Curr Med Chem; 2024 May; ():. PubMed ID: 38797910
[TBL] [Abstract][Full Text] [Related]
8. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
[TBL] [Abstract][Full Text] [Related]
9. Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.
Sachdeva H; Khaturia S; Saquib M; Khatik N; Khandelwal AR; Meena R; Sharma K
Appl Biochem Biotechnol; 2022 Dec; 194(12):6438-6467. PubMed ID: 35900713
[TBL] [Abstract][Full Text] [Related]
10. New Approaches for the Synthesis of Heterocyclic Compounds Corporating Benzo[d]imidazole as Anticancer Agents, Tyrosine, Pim-1 Kinases Inhibitions and their PAINS Evaluations.
Mohareb RM; Milad YR; Mostafa BM; El-Ansary RA
Anticancer Agents Med Chem; 2021; 21(3):327-342. PubMed ID: 32698742
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
[TBL] [Abstract][Full Text] [Related]
12. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
13. 1,3,4-Oxadiazole Containing Compounds As Therapeutic Targets For Cancer Therapy.
Ahsan MJ
Mini Rev Med Chem; 2022; 22(1):164-197. PubMed ID: 33634756
[TBL] [Abstract][Full Text] [Related]
14. Updates on Receptors Targeted by Heterocyclic Scaffolds: New Horizon in Anticancer Drug Development.
Kharb R
Anticancer Agents Med Chem; 2021; 21(11):1338-1349. PubMed ID: 32560614
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.
Lang DK; Kaur R; Arora R; Saini B; Arora S
Anticancer Agents Med Chem; 2020; 20(18):2150-2168. PubMed ID: 32628593
[TBL] [Abstract][Full Text] [Related]
16. Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets.
Mushtaq A; Wu P; Naseer MM
Pharmacol Ther; 2024 Feb; 254():108579. PubMed ID: 38160914
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines.
Tandon R; Singh I; Luxami V; Tandon N; Paul K
Chem Rec; 2019 Feb; 19(2-3):362-393. PubMed ID: 29943894
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy.
Kumar L; Verma S; Joshi K; Sharma S
Crit Rev Ther Drug Carrier Syst; 2023; 40(3):47-94. PubMed ID: 36749083
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M
Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031
[TBL] [Abstract][Full Text] [Related]
20. Benzothiazoles: how relevant in cancer drug design strategy?
Singh M; Singh SK
Anticancer Agents Med Chem; 2014 Jan; 14(1):127-46. PubMed ID: 23869774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
